EA200000160A1 - Новые соли с полезными органолептическими свойствами - Google Patents

Новые соли с полезными органолептическими свойствами

Info

Publication number
EA200000160A1
EA200000160A1 EA200000160A EA200000160A EA200000160A1 EA 200000160 A1 EA200000160 A1 EA 200000160A1 EA 200000160 A EA200000160 A EA 200000160A EA 200000160 A EA200000160 A EA 200000160A EA 200000160 A1 EA200000160 A1 EA 200000160A1
Authority
EA
Eurasian Patent Office
Prior art keywords
organoleptic properties
new salts
useful organoleptic
useful
salts
Prior art date
Application number
EA200000160A
Other languages
English (en)
Other versions
EA002719B1 (ru
Inventor
Ласло Ледницки
Иштван Шереш
Original Assignee
Хиноин Дьедьсер Эш Ведьесети Термекек Дьяра Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хиноин Дьедьсер Эш Ведьесети Термекек Дьяра Рт. filed Critical Хиноин Дьедьсер Эш Ведьесети Термекек Дьяра Рт.
Publication of EA200000160A1 publication Critical patent/EA200000160A1/ru
Publication of EA002719B1 publication Critical patent/EA002719B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Изобретение относится к новым солям известных лекарств, которые имеют приятный вкус.Отчет о международном поиске был опубликован1999.08.12.
EA200000160A 1997-07-25 1998-07-22 Новые соли с полезными органолептическими свойствами EA002719B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9701293A HUP9701293A3 (en) 1997-07-25 1997-07-25 New salts without unsavoury taste and pharmaceutical compositions containing them
PCT/HU1998/000066 WO1999004822A2 (en) 1997-07-25 1998-07-22 New salts with beneficial organoleptic properties

Publications (2)

Publication Number Publication Date
EA200000160A1 true EA200000160A1 (ru) 2000-10-30
EA002719B1 EA002719B1 (ru) 2002-08-29

Family

ID=89995415

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000160A EA002719B1 (ru) 1997-07-25 1998-07-22 Новые соли с полезными органолептическими свойствами

Country Status (14)

Country Link
EP (1) EP1003557B1 (ru)
AR (1) AR016540A1 (ru)
AU (1) AU8553598A (ru)
EA (1) EA002719B1 (ru)
EE (1) EE04098B1 (ru)
GE (1) GEP20022613B (ru)
HR (1) HRP20000037A2 (ru)
HU (1) HUP9701293A3 (ru)
PL (1) PL344038A1 (ru)
SK (1) SK284641B6 (ru)
TW (1) TW509569B (ru)
UA (1) UA69390C2 (ru)
WO (1) WO1999004822A2 (ru)
YU (1) YU3400A (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10013712A1 (de) * 2000-03-20 2001-09-27 Nutrinova Gmbh Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
US20020081360A1 (en) * 2000-12-27 2002-06-27 Andreas Burgard Salts of L-amino acid having improved taste and their preparation
DE10130504B4 (de) 2001-06-25 2005-02-03 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Xanthin- und Phenazon-Acesulfam-H-Komplexe mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
CA2709219A1 (en) * 2007-12-12 2009-06-18 Ultimorphix Technologies B.V. Solid forms of tenofovir disoproxil
US7935817B2 (en) * 2008-03-31 2011-05-03 Apotex Pharmachem Inc. Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
CN103664781B (zh) * 2013-12-13 2015-12-09 浙江普洛康裕制药有限公司 盐酸屈他维林晶型i和晶型ii及制备方法
CN103694171B (zh) * 2013-12-13 2016-06-29 浙江普洛康裕制药有限公司 盐酸屈他维林晶型iii和晶型iv及其制备方法
WO2024023785A1 (en) * 2022-07-29 2024-02-01 Berlia Sushma Paul A stable pharmaceutical oral liquid formulation of an antispasmodic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621917A (ru) *
GB1577196A (en) * 1977-06-03 1980-10-22 Ile De France Compositions containing erythromycin and metoclopramide
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
NZ230701A (en) * 1988-09-20 1992-01-29 Glaxo Group Ltd Pharmaceutical compositions comprising ranitidine, alginic acid and a carbonate or bicarbonate

Also Published As

Publication number Publication date
SK284641B6 (sk) 2005-08-04
YU3400A (sh) 2002-03-18
AU8553598A (en) 1999-02-16
EP1003557B1 (en) 2003-05-02
HRP20000037A2 (en) 2000-10-31
WO1999004822A2 (en) 1999-02-04
EE200000049A (et) 2000-10-16
UA69390C2 (ru) 2004-09-15
HU9701293D0 (en) 1997-09-29
GEP20022613B (en) 2002-01-25
HUP9701293A3 (en) 1999-08-30
TW509569B (en) 2002-11-11
AR016540A1 (es) 2001-07-25
EE04098B1 (et) 2003-08-15
PL344038A1 (en) 2001-09-24
WO1999004822A3 (en) 1999-08-12
EA002719B1 (ru) 2002-08-29
HUP9701293A2 (hu) 1999-02-01
SK1072000A3 (en) 2000-11-07
EP1003557A2 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
ID18249A (id) Turunan 6,5-hetero-bisiklik tersubstitusi
FR2689694B1 (fr) Laser doublé en fréquence, à fréquence unique.
TR199600029A2 (tr) 2,8-disübstitüe edilmis kinazolinonlar.
FI922234A0 (fi) Kompositioner med laog loeslighet, vilka utgoers av paerlor belagda med laekemedel.
NO900619D0 (no) Substituerte 1,3-okstiolaner.
DE69809755D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalin derivate
MX9204258A (es) Sintesis asimetrica de la cadena lateral de taxol.
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DE58904761D1 (de) Chirale derivate des 1,2 -difluorbenzols.
ID26310A (id) Produksi kontinyu 1,3-dioksolan-2-ona
FR2713190B1 (fr) Structure de chenille.
TR28098A (tr) 1,2,4-okzadiazol türevleri.
MA23778A1 (fr) Purine-6-ones-2,9 disubstituees
TR27961A (tr) Sübstitüe edilmis 1,2,3,4 -tetrahidro-5-nitro-pirimidinler.
MA26503A1 (fr) Derives de 5'-desoxy-cytidine.
TR199700601A3 (tr) Bir aromalandirici maddenin üretimi.
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
EA200000160A1 (ru) Новые соли с полезными органолептическими свойствами
ITRM940393A0 (it) "macchina per la fabbricazione di sigarette".
DE69628458D1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalceriferol derivate
DE69906149D1 (de) 4,5-azolo-oxindole
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
DE58903514D1 (de) Derivate der 2,3-difluorbenzoesaeure.
DE69203060D1 (de) Schweissbolzen.
DE69828906D1 (de) Herstellung von 1,3 propandiolestern

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU